👤 Silke Reischmann-Düsener

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
3
Articles
articles
Simon Braumann, Tilo Thottakara, Sabrina Stücker +7 more · 2018 · Frontiers in physiology · Frontiers · added 2026-04-24
no PDF DOI: 10.3389/fphys.2018.01292
MYBPC3
Sonia R Singh, Antonia T L Zech, Birgit Geertz +10 more · 2017 · Circulation. Heart failure · added 2026-04-24
Alterations in autophagy have been reported in hypertrophic cardiomyopathy (HCM) caused by Danon disease, Vici syndrome, or LEOPARD syndrome, but not in HCM caused by mutations in genes encoding sarco Show more
Alterations in autophagy have been reported in hypertrophic cardiomyopathy (HCM) caused by Danon disease, Vici syndrome, or LEOPARD syndrome, but not in HCM caused by mutations in genes encoding sarcomeric proteins, which account for most of HCM cases. We evaluated autophagy in patients with HCM carrying Altogether, we found that (1) autophagy is altered in patients with HCM carrying Show less
no PDF DOI: 10.1161/CIRCHEARTFAILURE.117.004140
MYBPC3
Frederik Flenner, Birgit Geertz, Silke Reischmann-Düsener +4 more · 2017 · The Journal of physiology · added 2026-04-24
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac illness and can lead to diastolic dysfunction, sudden cardiac death and heart failure. Treatment of HCM patients is empirical and Show more
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac illness and can lead to diastolic dysfunction, sudden cardiac death and heart failure. Treatment of HCM patients is empirical and current pharmacological treatments are unable to stop disease progression or reverse hypertrophy. In this study, we tested if the non-dihydropyridine Ca Left ventricular hypertrophy, diastolic dysfunction and fibrosis are the main features of hypertrophic cardiomyopathy (HCM). Guidelines recommend β-adrenoceptor or Ca Show less
no PDF DOI: 10.1113/JP273769
MYBPC3